OncoResponse Investors

29 investors on Angel Roster list OncoResponse in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name OncoResponse can appear together.

Investors listed
29
With verified email
45%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 29 OncoResponse investors

The most complete profiles first. Showing 29 of 29.

  • Carol SuhVerified

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • David CruikshankVerified

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceBiotechnologyHardware

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Eric YoungVerified

    Venture Capital, Founder, Investor · United Kingdom

    SeedSeries BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Filanet, Hallo and 85 more

    Verified email available

  • Guy RussoVerified

    Venture Capital, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Verified email available

  • Jared NewmanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Verified email available

  • Joydeep BhattacharyyaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceCybersecurity

    Portfolio: BoostUp.ai, Node, OncoResponse, Hallo and 84 more

    Verified email available

  • Laura ChauVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Verified email available

  • Sean KendallVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareEnterprise SoftwareEnergyChemical

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Tim ShannonVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 83 more

    Verified email available

  • Wende HuttonVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: OncoResponse, Apieron, Hyalex Orthopaedics, Calibra Medical and 12 more

    Verified email available

  • Hootan RashidifardVerified

    Venture Capital · United States

    AdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Verified email available

  • Mark McDonnellVerified

    Venture Capital · United States

    Health CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Rob FaulknerVerified

    Hedge Fund, Venture Capital, Private Equity Firm · United States

    Health CareHospitalsGeneticsWomen Founded

    Portfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more

    Contact details available

  • Tom BrennanVerified

    Venture Capital, Private Equity Firm · United States

    Health CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Corey Ritter

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceRoboticsManufacturing

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Contact details available

  • Derek Rapp

    Venture Capital, Private Equity Firm, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareLife Science

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • Isaac Zike Ph.D.

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • Jay Schmelter

    Venture Capital, Founder, Private Equity Firm · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareLife Science

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • John McKearn

    Venture Capital, Private Equity Firm, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareLife Science

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • Karen Spilizewski

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • Nancy Hong, PhD

    Venture Capital, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareLife Science

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 37 more

    Contact details available

  • Nandu Anilal

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Contact details available

  • Nilay Thakar

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Contact details available

  • Rayfe Gaspar

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Contact details available

  • Steve Gillis

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 68 more

    Contact details available

  • Tom Melzer

    Venture Capital, Founder, Investor · United States

    Series BSeries AHealth CareWomen FoundedEnterprise SoftwareLife Science

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • Byron Ling

    Venture Capital · United States

    AdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Contact details available

  • Gerard van Hamel Platerink

    Hedge Fund, Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more

    Contact details available

  • Robert Nelsen

    Venture Capital, Investor · United States

    Health CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 78 more

    Contact details available

Frequently asked questions

How many OncoResponse investors are on Angel Roster?

Angel Roster lists 29 OncoResponse investors. 13 of them (45%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (29), Private Equity Firms (18) and Founder-Investors (3). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do OncoResponse investors invest in?

Among those that list a stage, the most common are Series B (16), Series A (10) and Seed (7).

Where are OncoResponse investors based?

Most are based in the United States (27) and the United Kingdom (2).

Which companies have OncoResponse investors backed?

The most-backed portfolio companies among them are Mantra Health (11), Verve Therapeutics (11), Glooko (11), Scholar Rock (11) and Hyalex Orthopaedics (11).

How do I contact OncoResponse investors?

Create a free Angel Roster account to search and filter all 29, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.